Serotonin Receptor Type 3 Antagonists Improve Obesity-Associated Fatty Liver Disease in MiceSynia Haub, Stephan C. Bischoff, Astrid Hubert et al.|Journal of Pharmacology and Experimental Therapeutics|2011Cited by 64
PP054 CRITICAL ROLE OF THE INTESTINAL SEROTONIN RECEPTOR 3 IN THE DEVELOPMENT OF NON-ALCOHOLIC STEATOHEPATITIS IN MICESynia Haub, Stephan C. Bischoff, Yvonne Ritze et al.|Clinical Nutrition Supplements|2010Cited by 0